3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Actovegin: new trials by email Literature Review of Actovegin trials Research Report on Actovegin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB Actovegin, Placebo - Peripheral Arterial Diseases | Phase 3 | Completed | Takeda | 366 | 2018-05-01 | 2020-10-28 |
| Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI) Actovegin, Placebo - Post-Stroke Cognitive Impairment (PSCI) | Phase 3 | Completed | Takeda | 503 | 2012-06-01 | 2016-02-22 |
| Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM) Deproteinised hemoderivative of calf blood (Actovegin) - Symptomatic Diabetic Peripheral Polyneuropathy | Phase 3 | Completed | Nycomed | 569 | 2006-12-01 | 2012-05-07 |
Cognition Disorders (1) · Peripheral Arterial Disease (1) · Stroke (1)
Kazakhstan (2) · Russia (2) · Belarus (1) · Denmark (1) · Georgia (1)
2017 (1)